Gene · 2548
Papers2,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and Functional Characterization of Novel AGL Variants in Two Families with Glycogen Storage Disease Type III. | Int J Endocrinol | 2023 | 37287601 | PubTator, text mining | PubMed |
| Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease: An experience from the French Pompe Registry. | Mol Genet Metab | 2023 | 37285781 | PubTator, text mining | PubMed |
| Multiplex tandem mass spectrometry enzymatic activity assay for the screening and diagnosis of Mucolipidosis type II and III. | Mol Genet Metab Rep | 2023 | 37275682 | PubTator, text mining | PubMed |
| Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist's perspective. | Front Neurol | 2023 | 37265469 | PubTator, text mining | PubMed |
| Study on the Mechanism of Naoxintong in the Treatment of Cerebral Ischemia-Reperfusion Injury Based on a Multiomics Method. | Rejuvenation Res | 2023 | 37261991 | PubTator, text mining | PubMed |
| Multi-omic approach characterises the neuroprotective role of retromer in regulating lysosomal health. | Nat Commun | 2023 | 37248224 | PubTator, text mining | PubMed |
| Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review. | Int J Mol Sci | 2023 | 37239976 | PubTator, text mining | PubMed |
| Metabolic Myopathies in the Era of Next-Generation Sequencing. | Genes (Basel) | 2023 | 37239314 | PubTator, text mining | PubMed |
| Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy. | Biomark Res | 2023 | 37231524 | PubTator, text mining | PubMed |
| Non-invasive diagnostic potential of salivary miR-25-3p for periodontal disease and osteoporosis among a cohort of elderly patients with type 2 diabetes mellitus. | BMC Oral Health | 2023 | 37221590 | PubTator, text mining | PubMed |
| Large-scale expansions of Friedreich's ataxia GAA•TTC repeats in an experimental human system: role of DNA replication and prevention by LNA-DNA oligonucleotides and PNA oligomers. | Nucleic Acids Res | 2023 | 37216608 | PubTator, text mining | PubMed |
| [Analysis of lysosomal enzyme activity and genetic variants in a child with late-onset Pompe disease]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 | 37212008 | PubTator, text mining | PubMed |
| [A prospective study of genetic screening of 2 060 neonates by high-throughput sequencing]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2023 | 37211996 | PubTator, text mining | PubMed |
| Characteristic of molecular subtype based on lysosome-associated genes reveals clinical prognosis and immune infiltration of gastric cancer. | Front Oncol | 2023 | 37197421 | PubTator, text mining | PubMed |
| A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation. | Sci Rep | 2023 | 37188686 | PubTator, text mining | PubMed |
| Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD). | Curr Issues Mol Biol | 2023 | 37185710 | PubTator, text mining | PubMed |
| Cipaglucosidase Alfa: First Approval. | Drugs | 2023 | 37184753 | PubTator, text mining | PubMed |
| Role of non-coding variants in cardiovascular disease. | J Cell Mol Med | 2023 | 37183561 | PubTator, text mining | PubMed |
| Spatial metabolomics reveals glycogen as an actionable target for pulmonary fibrosis. | Nat Commun | 2023 | 37179348 | PubTator, text mining | PubMed |
| Generation of two induced pluripotent stem cell lines (CHOCi002-A and CHOCi003-A) from Pompe disease patients with compound heterozygous mutations in the GAA gene. | Stem Cell Res | 2023 | 37167752 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2548/papers?page=17